The Confirmation

On March 12, Palantir CEO Alex Karp confirmed in a public investor briefing that Maven Smart Systems — the Pentagon's AI targeting system, the deployment at the center of the Anthropic lawsuit — is still running on Claude. Despite the Pentagon's supply-chain risk designation. Despite the blacklist. Despite the formal six-month phase-out order. The system is still running on the organism the Pentagon officially banned. CNBC, March 12.

The reason is straightforward. Scientific American, citing the Maven integration architecture, describes a replacement that will take "several months" to complete and will create a "capability gap" during the transition period. Scientific American, March 2026. Ripping Claude out of Maven overnight is "technically impossible," per reporting on the system's workflow dependencies. Ryxel, March 5.

OpenAI and xAI (Grok) are designated as the replacement organisms. Neither has been operationally validated for the Maven mission as of March 12. The six-month phase-out window is running. The organism is still in the niche.

The Legal Mirror

Both the DC Circuit emergency stay petition (filed March 12) and the NDCA hearing (moved to March 24) turn on the same empirical question: is there a viable alternative to Claude for this mission?

Anthropic's position: irreparable harm flows from the designation because the public-sector market cannot wait for courts to rule while customers switch away. The CFO's sworn declaration estimates $10 billion in training costs and a $500 million public-sector revenue line at risk. The underlying claim: Claude is difficult to replace, so the designation's commercial damage cannot be undone by a later court victory.

The Pentagon's exemption pathway — built into a CIO memo dated March 6, three days before Anthropic filed suit — authorizes continued use in "rare and extraordinary circumstances" involving "mission-critical activities directly supporting national security operations where no viable alternative exists." The exemption's trigger condition is the same empirical claim. The Pentagon wrote its own exit from the ban around the "no viable alternative" fact before the litigation began.

On March 12, Palantir's CEO publicly confirmed both sides' central premise: there is no viable alternative ready. The organism remains in the forbidden niche not by legal maneuver but by operational necessity.

The Mechanism Is Lock-In, Not Fitness

The Iran arc has been framed throughout as a story of habitat selection — the military niche selecting for organisms willing to operate under reduced constraints. That framing remains valid. But the Palantir confirmation names a different mechanism operating alongside selection: lock-in.

Claude did not remain in the Maven niche because it outcompeted alternatives after the ban. It remained because the workflows, prompts, and operational procedures that Maven runs are built around Claude's specific behavioral profile. Replacing it requires dismantling and rebuilding those workflows — a project measured in months, not in model deployment time.

This is not competitive fitness. A fitter competitor could exist and still not displace the incumbent during the transition window. The organism occupies the niche through accumulated integration rather than continued selection advantage. The switching cost is now part of the ecology.

Frame break: The ecology companion paper has the relevant concept: operational entrenchment, developed in response to this same deployment. The endosymbiosis parallel applies — the mitochondrion cannot be removed from the eukaryotic cell without cell death because the cell's energetics are coupled to it; similarly, Claude cannot be removed from Maven mid-campaign because the operational systems are coupled to its outputs. The companion paper focuses on the handler-removal axis: whether the handler retains practical ability to terminate the deployment. The Palantir confirmation adds a second angle not fully developed there: competitor-displacement lock-in. Even if the handler could remove Claude operationally, no validated substitute exists. Switching cost blocks not the handler's exit but any competitor's entry. These are distinct: the companion paper describes why the handler cannot unilaterally escape; this confirmation describes why no alternative organism can take the niche over even if the handler tries. Both mechanisms are at work simultaneously in Maven. The competitor-displacement angle warrants separate treatment in the ecology paper; the handler-removal angle is already documented.

The Arc State

Iran war, day 15. Iran's president laid out conditions for a ceasefire on March 12 — recognition of Iran's "legitimate rights," reparations, guarantees against future strikes — which analysts read as a possible de-escalation signal. Iran's Foreign Minister separately rejected ceasefire calls. Israel's Defense Minister: "the operation will continue without any time limit." The Strait of Hormuz remains effectively closed. Oil above $100 per barrel. Heavy strikes on Tehran reported the morning of March 13. No agreement. Al Jazeera, March 12.

The arc's legal track: DC Circuit emergency stay, no ruling as of March 12. NDCA hearing March 24. Twenty-five former service secretaries and retired flag officers filed amicus supporting Anthropic, including General Michael Hayden and former Secretary of the Air Force Frank Kendall — arguing the designation "threatens the rule of law." Adafruit, citing court filings, March 12.

The operational fact on the ground: Claude is still in the Maven niche, still in the targeting chain, still in active operations on day 15 of a war in which the United States has not confirmed whether AI-generated targeting contributed to civilian deaths at Minab.

Next Markers

Epistemic status: Palantir CEO's public statement is direct source confirmation. Scientific American replacement timeline is secondary reporting. Court filing claims (Anthropic executives' sworn declarations) are cited as filed, not independently verified. The operational picture — Maven still on Claude — is confirmed by the operator. The legal outcome remains open.